Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | AR | P10275 | 5/20 | 0.37 |
| ▸ | PKM | P14618 | 1/20 | 0.37 |
| ▸ | CNR1 | P21554 | 1/20 | 0.36 |
| ▸ | PGR | P06401 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6524805 | 0.92 | CNR1 (0.39) | ARCNR1PGR | |
| SCHEMBL3659657 | 0.90 | AR (0.40) | ARCNR1PGR | |
| SCHEMBL1972193 | 0.89 | AR (0.48) | ARPGR | |
| SCHEMBL1973862 | 0.87 | CNR1 (0.41) | ARCNR1PGR | |
| SCHEMBL6519999 | 0.87 | CNR1 (0.43) | ARCNR1PGR | |
| SCHEMBL1974760 | 0.87 | CNR1 (0.43) | ARCNR1PGR | |
| SCHEMBL6521558 | 0.86 | CNR1 (0.42) | ARCNR1PGR | |
| SCHEMBL1973173 | 0.86 | CNR1 (0.50) | ARCNR1 | |
| SCHEMBL1975686 | 0.86 | CNR1 (0.42) | ARCNR1PGR | |
| SCHEMBL8021094 | 0.84 | CNR1 (0.40) | ARCNR1PGR |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20110053947-A1 | Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof | SANOFI-AVENTIS (FR) | 2011-03-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20110053947-A1 | Arylchalcogenoarylalkyl-substituted imidazolidine-2,4-diones, process for preparation thereof, medicaments comprising these compounds and use thereof | PGC, LIPC, CEL | AR 1971/4885PKM 979/4885CNR1 277/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.